These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 32939795)

  • 41. Anastrozole-induced subacute cutaneous lupus erythematosus.
    Fisher J; Patel M; Miller M; Burris K
    Cutis; 2016 Aug; 98(2):E22-6. PubMed ID: 27622265
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative analysis of subacute cutaneous lupus erythematosus and chronic cutaneous lupus erythematosus: clinical and immunological study of 270 patients.
    Vera-Recabarren MA; García-Carrasco M; Ramos-Casals M; Herrero C
    Br J Dermatol; 2010 Jan; 162(1):91-101. PubMed ID: 19785596
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Cutaneous lupus erythematosus].
    Sandreva T; Voss A; Bygum A
    Ugeskr Laeger; 2015 Jul; 177(31):. PubMed ID: 26238007
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Alendronate induced subacute cutaneous lupus erythematosus successfully treated with intravenous immunoglobulin.
    Uzuncakmak TK; Bayazit S; Askin O; Engin B; Ugurlu S; Sar M; Serdaroglu S
    Dermatol Ther; 2020 Nov; 33(6):e14477. PubMed ID: 33125828
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical, histologic, and immunofluorescent distinctions between subacute cutaneous lupus erythematosus and discoid lupus erythematosus.
    David-Bajar KM; Bennion SD; DeSpain JD; Golitz LE; Lee LA
    J Invest Dermatol; 1992 Sep; 99(3):251-7. PubMed ID: 1512459
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [When drugs induce cutaneous lupus erythematosus].
    Skovmøller KB; Bygum A
    Ugeskr Laeger; 2018 Oct; 180(41):. PubMed ID: 30327081
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Are there distinct clinical and pathological features distinguishing idiopathic from drug-induced subacute cutaneous lupus erythematosus? A European retrospective multicenter study.
    Guicciardi F; Atzori L; Marzano AV; Tavecchio S; Girolomoni G; Colato C; Villani AP; Kanitakis J; Mitteldorf C; Satta R; Cribier B; Gusdorf L; Rossi MT; Calzavara-Pinton P; Bielsa I; Fernandez-Figueras MT; Kempf W; Filosa G; Pilloni L; Rongioletti F
    J Am Acad Dermatol; 2019 Aug; 81(2):403-411. PubMed ID: 30763648
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Docetaxel (taxotere) induced subacute cutaneous lupus erythematosus: report of 4 cases.
    Chen M; Crowson AN; Woofter M; Luca MB; Magro CM
    J Rheumatol; 2004 Apr; 31(4):818-20. PubMed ID: 15088316
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Subacute cutaneous lupus erythematosus following ribociclib therapy for metastatic breast cancer.
    Collada Sánchez VL; Álvarez Criado J; Martinez Martin V; Zamora Auñon P; Espinosa Arranz E; Mayor Ibarguren A; Nacher Jimenez I; Herrero Ambrosio A
    J Oncol Pharm Pract; 2023 Oct; 29(7):1793-1796. PubMed ID: 37455486
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Paraneoplastic subacute cutaneous lupus erythematosus].
    Rezazadegan R; Koushk-Jalali B; Kuntz T; Oellig F; Tigges C; Kreuter A
    Z Rheumatol; 2021 Mar; 80(2):189-193. PubMed ID: 33236165
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Subacute cutaneous lupus erythematosus on the lines of Blaschko.
    Röckmann H; Feller G; Schadendorf D; Goerdt S
    Eur J Dermatol; 2006; 16(3):302-6. PubMed ID: 16709500
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Leflunomide in subacute cutaneous lupus erythematosus - two sides of a coin.
    Suess A; Sticherling M
    Int J Dermatol; 2008 Jan; 47(1):83-6. PubMed ID: 18173611
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Subacute cutaneous lupus erythematosus induced and exacerbated by proton pump inhibitors.
    Almebayadh M; Regnier-Rosencher E; Carlotti A; Goulvestre C; Le Guern V; Mouthon L; Avril MF; Dupin N
    Dermatology; 2013; 226(2):119-23. PubMed ID: 23548825
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Subacute Cutaneous Lupus Erythematosus: Clinical Characteristics, Disease Associations, Treatments, and Outcomes in a Series of 90 Patients at Mayo Clinic, 1996-2011.
    Alniemi DT; Gutierrez A; Drage LA; Wetter DA
    Mayo Clin Proc; 2017 Mar; 92(3):406-414. PubMed ID: 28185656
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Drug-induced lupus erythematosus.
    Vedove CD; Del Giglio M; Schena D; Girolomoni G
    Arch Dermatol Res; 2009 Jan; 301(1):99-105. PubMed ID: 18797892
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A difficult diagnosis: drug-induced subacute cutaneous lupus erythematosus (SCLE) triggered by omeprazole in a patient with pre-existing idiopathic SCLE.
    Wee JS; Natkunarajah J; Marsden RA
    Clin Exp Dermatol; 2012 Jun; 37(4):445-6. PubMed ID: 22420369
    [No Abstract]   [Full Text] [Related]  

  • 57. [Classification of dermatologic manifestations in lupus erythematosus].
    Francès C; Barete S; Ayoub N; Piette JC
    Ann Med Interne (Paris); 2003 Feb; 154(1):33-44. PubMed ID: 12746657
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Subacute cutaneous lupus erythematosus presenting in childhood: a case report and review of the literature.
    Berry T; Walsh E; Berry R; DeSantis E; Smidt AC
    Pediatr Dermatol; 2014; 31(3):368-72. PubMed ID: 23106790
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Subacute cutaneous lupus erythematosus presenting as poikiloderma.
    Hughes R; Loftus B; Kirby B
    Clin Exp Dermatol; 2009 Dec; 34(8):e859-61. PubMed ID: 20055848
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tissue eosinophilia: not an indicator of drug-induced subacute cutaneous lupus erythematosus.
    Hillesheim PB; Bahrami S; Jeffy BG; Callen JP
    Arch Dermatol; 2012 Feb; 148(2):190-3. PubMed ID: 22004879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.